Riders For The Cure - Working to Cure Cancer

  • Increase font size
  • Default font size
  • Decrease font size

Ride For Life

Event Date: June 4, 2011

Ride For Life, a police-escorted motorcycle ride, will take place Saturday, June 4 2011. Registration starts at 9:30 a.m., and kickstands go up at 11am. The cost is $20 per rider, which includes lunch, and a pin. The ride will start and end at Stubbs Harley-Davidson in Houston on Telephone Road. There will be door prizes, food and entertainment.

This event supports Anderson Network’s annual patient and caregiver conference held in September. The ride is one of many events commemorating National Cancer Survivor’s Day at M. D. Anderson during the week of June 5-11. National Cancer Survivor’s Day is held annually on the first Sunday in June in hundreds of communities worldwide to celebrate survivors and their caregivers. A calendar of survivorship week events will be available on M. D. Anderson’s Survivorship Web site during the month of May.

 

Upcoming Rides

Ride for Life 2012:

June 2nd, 2012 at 9:30 A.M.

Ride For Life, a police-escorted motorcycle ride, will take place Saturday, June 2nd 2012.

Registration for this ride starts at 9:30 a.m., and kickstands go up at 11am. The cost is $20 per rider, which includes lunch, and a pin. The ride will start and end at Stubbs Harley-Davidson in Houston on Telephone Road. There will be door prizes, food and entertainment.

Read More? View Our Online Flyer Register Here

Sam’s Jam V:

October 13th, 2012

This will be the 5th year for Sam's Jam and we look forward to seeing everyone at the event.

Mark your calendars!

View Our Online Flyer

Studies Currently Supported...

STUDIES SUPPORTED

Phase I/II study of reirradiation of recurrent or progressive brainstem glioma:

 

This study investigates the use of re-irradiation in the highly aggressive form of cancer known as brainstem glioma. This Phase I/II study will be conducted to evaluate the safety of re-irradiation with higher doses. The main goal of treatment will be to improve symptoms and quality of life. This protocol may identify the optimal dose of re-irradiation and define the efficacy, particularly regarding quality of life, therefore offering a treatment option for patients with an incurable disease.

 

Principal Investigators: Anita Mahajan, M.D. and Hiral P Fontanilla, M.D.